Abintus Bio

Abintus Bio

Pioneering in vivo genetic medicines to engineer immune cells directly inside the body for treating lymphoma and solid tumors. Learn more

Launch date
Employees
Market cap
-
Enterprise valuation
€57—85m (Dealroom.co estimates Aug 2022.)
San Diego California (HQ)
Authorizing premium user...